Home › cardiovascular
 

Keywords :   


Tag: cardiovascular

X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG

2014-12-29 01:28:39| drugdiscoveryonline Home Page

X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, recently announced it has licensed a second drug discovery program to Bayer Pharma AG pursuant to the multi-target collaboration the companies established in July 2012

Tags: program drug discovery licenses

 

Aiken Regional Medical Center Selects Digisonics Cardiovascular Information System

2014-12-12 11:30:52| Industrial Newsroom - All News for Today

Aiken Regional Medical Center in Aiken, S.C. has selected the Digisonics Cardiovascular Information System (CVIS) for their echo and cardiac/vascular catheterization studies.  The Digisonics CVIS provides the hospital's clinicians with the ability to quickly review images and create structured reports for their...

Tags: information system center medical

 
 

VYTORIN (ezetimibe/simvastatin) Significantly Reduced Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes in the Investigational IMPROVE-IT Study

2014-11-17 17:45:00| Merck.com - Product News

Dateline City: CHICAGO CHICAGO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the investigational IMPROVE-IT study met its primary and all secondary composite efficacy endpoints. Language: English Contact: MerckMedia Contact:Pam Eisele, 267-305-3558orInvestor Contact:Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: the events study reduced

 

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

2014-08-29 21:55:11| Chemicals - Topix.net

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO to include additional high-risk patient populations.

Tags: research program global explorer

 

Black carbon linked to increased cardiovascular risk; exacerbated by co-exposure to motor vehicle emissions

2014-08-26 12:30:33| Green Car Congress

Tags: black increased risk motor

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »